Nanohale AG (FYB) | WebDisclosure

Basculer en Français

8621	Companies
142891	Keywords
78626	Articles
76348	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 02/25/2025 at 06:35, 1 month 22 days ago

Le FYB203 de Formycon reçoit l'approbation réglementaire britannique

Réglementation Au Royaume-Uni Approbation Des Biosimilaires Formycon FYB203 Traitement Ophtalmique Partenariat Avec Teva
PRESS RELEASE

published on 02/25/2025 at 06:30, 1 month 22 days ago

Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®
Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®. Approval for treating retinal diseases granted by UK's MHRA

Regulatory Approval UK Biosimilar Formycon AHZANTIVE
BRIEF

published on 02/24/2025 at 11:31, 1 month 23 days ago

Formycon AG : Objectif de cours ajusté en raison des pressions du marché

Formycon AG Recommandation D'achat Pression Sur Les Prix Réduction Des Investissements Marché Des Biosimilaires
BRIEF

published on 02/24/2025 at 11:31, 1 month 23 days ago

Formycon AG: Price Target Adjusted Amid Market Pressures

Buy Recommendation Formycon AG Price Pressure Biosimilar Market Investment Reduction
PRESS RELEASE

published on 02/24/2025 at 11:26, 1 month 23 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates its research on Formycon AG, maintaining a Buy recommendation with a decreased target price from EUR 82 to EUR 46 due to higher price pressure and reduced investments in biosimilar portfolio

First Berlin Equity Research Buy Recommendation Research Update Formycon AG Biosimilar Portfolio
BRIEF

published on 02/20/2025 at 06:35, 1 month 27 days ago

Formycon Unveils Clinical Data for Ustekinumab Biosimilar FYB202 at ECCO Congress

Formycon AG Regulatory Approval Clinical Data Biosimilar FYB202
BRIEF

published on 02/20/2025 at 06:35, 1 month 27 days ago

Formycon dévoile les données cliniques du biosimilaire d'ustekinumab FYB202 au congrès de l'ECCO

Formycon AG FYB202 Biosimilaire Approbation Réglementaire Données Cliniques
PRESS RELEASE

published on 02/20/2025 at 06:30, 1 month 27 days ago

Formycon presents clinical data on ustekinumab biosimilar FYB202 at the ECCO Congress in Berlin
Formycon presents clinical data on ustekinumab biosimilar FYB202 at ECCO Congress, demonstrating comparability with Stelara. FYB202 approved in multiple regions

Clinical Data ECCO Congress Biosimilar Formycon Ustekinumab
BRIEF

published on 02/17/2025 at 09:32, 2 months 2 days ago

Formycon AG fait le point sur ses projets biosimilaires et ses ajustements stratégiques

Stratégie Commerciale Approbation De La FDA Biosimilaires Ajustements Financiers Réductions De Prix
BRIEF

published on 02/17/2025 at 09:32, 2 months 2 days ago

Formycon AG Updates on Biosimilar Projects and Strategic Adjustments

FDA Approval Biosimilars Financial Adjustments Commercial Strategy Price Discounts

Accesswire

Published on 04/18/2025 at 23:35, 17 hours 38 minutes ago

urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Published on 04/18/2025 at 01:20, 1 day 15 hours ago

Aston Bay Files Technical Report for Storm Copper Project Initial Mineral Resource Estimate
Published on 04/18/2025 at 00:42, 1 day 16 hours ago

Regency Silver Announces New CEO
Published on 04/18/2025 at 00:00, 1 day 17 hours ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Published on 04/17/2025 at 23:50, 1 day 17 hours ago

Fourth Quarter and Year-End 2024 Results

View all ACCESSWIRE

EQS Group

Published on 04/18/2025 at 18:00, 23 hours 13 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25.
Published on 04/18/2025 at 18:00, 23 hours 13 minutes ago

E-PANGO: Résultats annuels 2024
Published on 04/18/2025 at 17:54, 23 hours 18 minutes ago

VALBIOTIS SA: Compte-rendu de l’Assemblée générale mixte du 18 avril 2025
Published on 04/18/2025 at 17:52, 23 hours 20 minutes ago

Market entry in France – Cicor acquires significant business activities of Éolane
Published on 04/18/2025 at 17:45, 23 hours 28 minutes ago

Linedata Services: Déclaration des transactions sur actions propres opération du 16 avril 2025

Les Echos

Published on 04/18/2025 at 17:45, 23 hours 27 minutes ago

Saint-Gobain once again featured on CDP’s “Climate A List”
Published on 04/18/2025 at 17:45, 23 hours 27 minutes ago

Saint-Gobain figure une nouvelle fois sur la « Climate A List » établie par le CDP
Published on 04/18/2025 at 11:16, 1 day 5 hours ago

Déclaration hebdomadaire d'opérations effectuées du 14 au 17 avril 2025
Published on 04/18/2025 at 11:16, 1 day 5 hours ago

Disclosure of transactions in own shares from April 14 to April 17, 2025
Published on 04/18/2025 at 07:00, 1 day 10 hours ago

Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders

View all LES ECHOS COMFI WIRE